personalised medicine congress (eapm) - dr derick mitchell - november 2017

26
November 29 th , 2017 PATIENTS – SCIENCE – INDUSTRY 1 st European Alliance for Personalised Medicine Congress Derick Mitchell

Upload: ipposi

Post on 22-Jan-2018

772 views

Category:

Health & Medicine


1 download

TRANSCRIPT

November 29th, 2017

PATIENTS – SCIENCE – INDUSTRY

1st European Alliance for Personalised Medicine Congress

Derick Mitchell

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Heart of the PM Ecosystem?

“Just because a system has patient data at its core does not

mean it is patient-centric”

Jane Grimson

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Linking Personalised Medicine & Public Health

• Making better use of patient data (health, genomic, experience)

• Engaging citizens on discourse on precision health

• Improving Genetic Health Literacy

• Adapting HTA frameworks, Real-World Evidence,

• Tackling information governance, consent, Electronic Health Records

HOW CAN PM CHANGE PUBLIC HEALTH PRACTICE?

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Collaborative sensemaking

“We are witnessing the collapse of expertise and the rise of

collaborative sensemaking”

David Holzmer

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Evidence-based patient advocacy

In God We Trust…..…Everyone Else Bring Data!

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

IPPOSI? Who?IPPOSI

A patient-led organisation

that works with patients,

government, industry,

& science to put patients at

the heart of health innovation

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

IPPOSI Priorities + Members

20

Actively advocate for improved + equitable

patient access to Health Innovation

Promote meaningful patient involvement in

Health Research and Policy

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Patient-led activities

Health Hacks

Workshops

Consultations

Round-tables

Working Groups

Summer Schools

Conferences

Clinical Research

Health Information

Patient Data

Health Economics

Patient Registries

Dynamic Consent

Data Protection

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Incorporating the patient voice

• Hierarchical Rhetoric

• ‘Walking the walk’ at the highest possible level

Challenges:• Decision-makers never want to change their processes

• Patients are not trained in health policy, dialogue

• Many patient orgs are not focused on policy issues

“The perfect is the enemy of the good”

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

What do we need to enable use (& re-use) of patient data?

Good

EducationLegal

Frameworks

SOPsFrameworks of

Engagement

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

What we have learned…

• Trustworthiness is vital….• patients must believe that their data is secure and only used

for the purposes they consented to

• Equally….• create the situation where patients are the drivers of their

data, ensuring it is utilised to improve their health

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

IPPOSI & The European Patients Academy

• EUPATI produces Expert Patients on Medicines Research & Development

• Provides Training & Education

• Disseminates through national platforms

The project received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.

www.eupati.eu

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Roles change as a result of EUPATI course

Role Before EUPATI After

Member of patient organisation, not actively involved 17% 2%

Active role in a patient organisation 62% 71%

Leadership role in a patient organisation 62% 71%

Employee of a patient organisation 25% 23%

Volunteer role in a patient organisation 60% 67%

Presenting at conferences, workshops etc. 63% 83%

Advising a pharmaceutical company 13% 44%

Advising a regulatory agency 21% 42%

Advising a reimbursement agency 4% 8%

EUPATI Fellows are increasingly taking leadership roles and are engaging with pharma, regulators and HTA bodies. Role changes also imply identity shifts

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

The Power of Patient Education

7-month programme in Health Innovation

Blended Learning – online + workshops

3 x 6-week modules

• Clinical Trials

• Regulatory Affairs

• Health Technology Assessment

4 x Education Partners - UCD, TCD, HPRA, HIQA

1 elearning website - www.patientsinvolved.ie

21 Students from 9 counties

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Frameworks of Engagement

2008 - National Strategy for Service User Involvement in

Health and Social Services (DoHC & HSE)

---------------------------------------------------------------------------

2016 – Values in Action, QID Cultures of Person-centeredness (HSE)

2016 – Mental Health Local Recovery Groups (HSE)

2016 – Privacy Impact Assessment for Individual Health Identifier

(eHealth Ireland)

2017 - National Patient Experience Survey - Hospitals (HIQA, HSE, DoH)

2017 - National Clinical Effectiveness Committee – PPI Values

(DoH, NCEC)

2017 –Personas for Electronic Health Records (eHealth Ireland)

2017/18 - Patient Narrative Project on Person-centered care

(CSPD-HSE, IPPOSI)

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

The Patient Narrative Project

Reference: Phelan A., Rohde D., Casey M., Fealy G., Felle P., Lloyd H. & O’Kelly G. (2017) Patient Narrative Project for Person-Centred Co-ordinated Care. UCD, IPPOSI & HSE, Dublin.

Phases 1 + 2 + 3:

Person-centered, co-ordinated care

Person centered co-ordinated care

Phase 1

What people in Ireland want to experienceduring their care when they require anumber of health services at one time orover time

Phase 2 + 3

A framework that will hear peoples’ experiences of using more than one health service at a time

11 Focus

Groups

2 Online

Surveys

4 Regional

Workshops

Output: Statements (19) + Definition (1)

Online Survey

+ System

Partnerships

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Themes Emerging From Phase 1

My healthcare

experiences

Healthcare I am

confident in

My journey through

healthcare

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

My Journey through Healthcare

• My care includes issues that my health influences, such as finances, housing, employment, ability to travel and access to transport.

• I have services delivered by the most suitable healthcare staff in the correct setting and when I need them.

• I can have one person who will oversee and follow up on all my care.

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Phase 2

• http://www.hse.ie/yourvoicematters

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

• Survey remains live• Proof-of-Concept• Producing data on patients’ experience of care when they use

more than one health service

• Target: • 1000 stories nationally, particularly in relation to older people and

people with chronic conditions

• Channel through Integrated Care Programmes HSE

By end of 2017… By end of 2018…

A ‘tried and tested’ framework

• To hear a high volume of patients’ experiences through the online survey

• To use data to influence service design, delivery and improvement of integrated care

• A qualitative and quantitative evaluation of the proof of concept within the context of the HSE;

Integration into ‘business as usual’

• Framework (incl. resource implications) to be integrated into a ‘business as usual’ model

• Quality and Patient Safety Structures at CHO level will be essential

• QID publication: ‘Quality and Safety Committees; Guidance and resources’

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Patient Narratives in PM?

Right treatment, Right time, Right patient

at the right location, by the right provider, at the right cost

Minimally Disruptive Treatments

• Impact on clinical trial design

• Impact on clinical guidelines

• Impact on clinical practice

• Impact on service delivery, coordinationV-T Tran et al. (2015) Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions BMC Medicine 13:115

European Alliance for Personalised Medicine Congress29/11/2017 www.ipposi.ie

Where we want to get to…

INFORM ENGAGE EMPOWER